Michael Gilson advances computational drug discovery by combining molecular simulation with rigorous benchmarking of protein–ligand modeling. He contributes to blinded community challenges and best-practice datasets, and develops approaches to hydration thermodynamics and polarizable force fields to improve pose and affinity prediction.